Unlock stock picks and a broker-level newsfeed that powers Wall Street.
OTC Markets OTCPK - Delayed Quote USD

Electromedical Technologies, Inc. (EMED)

Compare
0.0002
0.0000
(0.00%)
At close: April 2 at 4:00:00 PM EDT
Loading Chart for EMED
  • Previous Close 0.0000
  • Open 0.0002
  • Bid 0.0001 x --
  • Ask 0.0002 x --
  • Day's Range 0.0002 - 0.0002
  • 52 Week Range 0.0001 - 0.0018
  • Volume 500,000
  • Avg. Volume 27,643,768
  • Market Cap (intraday) 171,008
  • Beta (5Y Monthly) 1.44
  • PE Ratio (TTM)
  • EPS (TTM) 0.0000
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Electromedical Technologies, Inc., a bioelectronics manufacturing and marketing company, provides medical devices for pain management in the United States. The company offers WellnessPro Plus, a bioelectronics therapy prescription device that is used by consumers and health care professionals to relieve chronic and acute pain. It also develops WellnessPro POD, a compact clinical-grade wearable device for pain management; and Wellness ION Pen, an interferential cold laser used to deliver targeted frequency stimulation to improve circulation and tissue healing, and reduce inflammation and pain. The company serves chiropractors, physiotherapists, pain management doctors and clinicians, natural medicine doctors, sports medicine doctors, and athletic trainers. Electromedical Technologies, Inc. was founded in 2002 and is headquartered in Scottsdale, Arizona.

electromedtech.com

6

Full Time Employees

December 31

Fiscal Year Ends

Recent News: EMED

View More

Performance Overview: EMED

Trailing total returns as of 4/2/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

EMED
50.00%
S&P 500 (^GSPC)
3.58%

1-Year Return

EMED
71.43%
S&P 500 (^GSPC)
8.94%

3-Year Return

EMED
99.46%
S&P 500 (^GSPC)
24.75%

5-Year Return

EMED
99.93%
S&P 500 (^GSPC)
124.42%

Compare To: EMED

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: EMED

View More

Valuation Measures

Annual
As of 4/2/2025
  • Market Cap

    171.01k

  • Enterprise Value

    2.56M

  • Trailing P/E

    0.30

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.12

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    2.78

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -182.03%

  • Return on Assets (ttm)

    -88.83%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    922.01k

  • Net Income Avi to Common (ttm)

    -1.68M

  • Diluted EPS (ttm)

    0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    34.81k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    690.35k

Research Analysis: EMED

View More

Company Insights: EMED

Research Reports: EMED

View More

People Also Watch